Clinical Trial Update: LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers [Phase 4]

View source ↗

Summary

Long-term follow-up results (16-20 years) from a Hepatitis B vaccination study in newborns of HBeAg-positive mothers, comparing with and without HBIG, Phase 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• Hepatitis B immune globulin

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2010-07-15